|
Significant covariates of CFHCSF in normal subjects. |
|||
| Co-Variables with CRHCSF |
rho |
P |
N |
|
|
|||
| Glucose @ 2 pm |
0.987 |
0.0018 |
8 |
| Sodium, mmol/L |
-0.812 |
0.0079 |
9 |
| Norepinephrine, baseline, pre-pain testing |
0.790 |
0.035 |
7 |
| Norepinephrine 15 min after bike exercise |
0.918 |
0.0035 |
7 |
| Heart rate, resting, pre-hand grip |
0.796 |
0.018 |
8 |
| Heart rate, hand grip, 1 min recovery |
0.818 |
0.013 |
8 |
| Heart rate, hand grip, 2 min recovery |
0.747 |
0.033 |
8 |
| Heart rate, hand grip, 3 min recovery |
0.756 |
0.049 |
8 |
| Heart rate, resting, pre-bike exercise |
0.825 |
0.043 |
6 |
| Heart rate, log, summed for the day |
-0.810 |
0.015 |
8 |
| Pain threshold for hyperthermia |
-0.844 |
0.017 |
8 |
| SF-36 Vitality |
-0.838 |
0.0092 |
8 |
| Self-Efficacy Scale – Manage Symptoms |
-0.851 |
0.0073 |
8 |
Baraniuk et al. BMC Neuroscience 2004 5:58 doi:10.1186/1471-2202-5-58 |
|||